ACET

Adicet Bio, Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$2.93

Price (1 Year)

$10.37 $2.93

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %0.9 / %30
Non-compliant assets / Total market cap %105 / %30
Non-compliant revenue / Total income %100 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases.

Website

Analysis (Turkish): ACET Hissesi Caiz mi, Helal mi? Adicet Bio, Inc. Katılım Analizi